Loading...
OTCM
YKLTY
Market cap5.04bUSD
Jul 09, Last price  
8.91USD
1D
0.00%
1Q
11.65%
Name

Yakult Honsha Co Ltd

Chart & Performance

D1W1MN
OTCM:YKLTY chart
P/E
8.90
P/S
0.81
EPS
162.45
Div Yield, %
2.23%
Shrs. gr., 5y
-1.76%
Rev. gr., 5y
5.98%
Revenues
515.76b
+3.22%
273,099,000,000317,335,000,000293,490,000,000290,678,000,000305,944,000,000312,552,000,000319,193,000,000350,322,000,000367,980,000,000390,412,000,000378,307,000,000401,569,000,000407,017,000,000406,004,000,000385,706,000,000415,116,000,000483,071,000,000503,079,000,000499,683,000,000515,760,244,000
Net income
46.90b
+2.99%
14,805,000,00016,675,000,00011,324,000,00013,248,000,00013,168,000,00013,291,000,00016,379,000,00022,543,000,00025,056,000,00028,843,000,00030,154,000,00034,064,000,00034,935,000,00039,735,000,00039,267,000,00044,917,000,00050,641,000,00051,006,000,00045,533,000,00046,895,295,000
CFO
55.26b
-34.74%
25,724,000,00025,177,000,00037,559,000,00039,535,000,00040,987,000,00033,444,000,00042,887,000,00048,579,000,00055,407,000,00062,149,000,00059,998,000,00061,989,000,00062,125,000,00062,791,000,00055,820,000,00073,390,000,00086,513,000,00070,702,000,00084,687,000,00055,264,305,000
Dividend
Sep 30, 20250.088969 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Founded in Tokyo, Japan, in 1935, Yakult Honsha Co., Ltd. is a diversified corporation engaged in the creation and sale of a broad spectrum of goods. Its principal activities span food and beverage items, beauty products, and pharmaceutical drugs. The company's extensive food and beverage division operates across several global territories, including Japan, the Americas, Asia and Oceania, and Europe. This segment provides various offerings such as fermented milk beverages, juices, and noodles, which are distributed to consumers through both direct-to-home delivery services and conventional retail outlets. Within its pharmaceutical operations, Yakult Honsha focuses on developing and commercializing specialized medicines. These include the anti-cancer medication Elplat, along with generic versions of anti-tumor agents like Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. Beyond these core areas, Yakult Honsha also participates in the cosmetics sector and notably owns a professional sports franchise, the Tokyo Yakult Swallows baseball team.
IPO date
Jan 23, 1980
Employees
29,880
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT